Skip to content
healthcare.dev

BELRAPZO

NDC 42367-521, bendamustine hydrochloride, injection, from Eagle Pharmaceuticals, Inc.

Product NDC
42367-521
Status
Listed
Labeler
Eagle Pharmaceuticals, Inc
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205580
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42367-521 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENDAMUSTINE HYDROCHLORIDE100 mg/4mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
42367-521-25423670521251 VIAL, MULTI-DOSE in 1 CARTON (42367-521-25) / 4 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9759a4ae-82ca-40cf-9c02-e1cadb21cbdc
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=42367-521

Use it

Look up 42367-521 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42367-521 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42367-521. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.